---
title: 'Endovascular Treatment to Improve Outcomes for Medium Vessel Occlusions: The
  ESCAPE-MeVO trial'
date: '2024-06-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38845180/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240607181555&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'RATIONALE: Clinical outcomes in acute ischemic stroke due to medium
  vessel occlusion (MeVO) are often poor when treated with best medical management.
  Data from non-randomized studies suggest that endovascular treatment (EVT) may improve
  outcomes in MeVO stroke, but randomized data on potential benefits and risks are
  hitherto lacking. Thus, there is insufficient evidence to guide endovascular treatment
  decision-making in MeVO ...'
disable_comments: true
---
RATIONALE: Clinical outcomes in acute ischemic stroke due to medium vessel occlusion (MeVO) are often poor when treated with best medical management. Data from non-randomized studies suggest that endovascular treatment (EVT) may improve outcomes in MeVO stroke, but randomized data on potential benefits and risks are hitherto lacking. Thus, there is insufficient evidence to guide endovascular treatment decision-making in MeVO ...